Search the Newsreel

Nexalin Technology Inc (NXL) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Nexalin Technology Inc (NXL), detailing its current earnings forecast score, average price target, and analyst rating. Based on one analyst, the company has a "Buy" rating with a target price indicating significant upside potential. Key financial forecasts …

NXL|Nexalin Technology Inc|Price:0.365|Chg%:+0.027

This article provides a comprehensive stock analysis of Nexalin Technology Inc (NXL) by TradingKey, highlighting its healthy fundamentals, good growth potential, and fair valuation. Key insights include high institutional ownership, a "Buy" rating from analysts with a target price of $2.00, and steady revenue …

Nexalin Expands and Extends Houston Headquarters Lease Commitment

Nexalin Technology, Inc. has announced the expansion and extension of its Houston headquarters lease at 1776 Yorktown with Nutex HQ LLC. The amendment, dated July 28, 2026, increases their premises from 3,623 to approximately 4,527 square feet and extends the lease term for 65 …

Nexalin Technology Inc (NXL) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Nexalin Technology Inc (NXL), detailing its price momentum score of 5.11 and ranking within the Healthcare Equipment & Supplies industry. It outlines the stock's current trading range between resistance at $0.46 and support at $0.27, suggesting suitability …

Nexalin Technology Inc (NXL) Cash Flow

This article provides Nexalin Technology Inc.'s (NXL) cash flow statement, offering both annual and quarterly data to assess the company's financial health. It details operating, investing, and financing cash flows, along with changes in working capital and capital expenditures. The report also includes FAQs …

Nexalin Technology Received Notice of Delisting

Nexalin Technology (NXL) received a delisting notice from Nasdaq on July 24, 2026, due to non-compliance with the $1.00 minimum bid price and failure to meet the $5,000,000 stockholders' equity requirement. Trading is scheduled for suspension on August 4, 2026, but the company has …

Nexalin Technology Inc (NXL) Institutional Confidence

The article provides an overview of Nexalin Technology Inc's (NXL) institutional confidence score and shareholding details. NXL has an institutional shareholding score of 3.00, placing it 130th in the Healthcare Equipment & Supplies industry, with institutional shareholding increasing by 79.03% quarter-over-quarter to 6.94%. James …

Nexalin Technology Inc (NXL) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Nexalin Technology Inc (NXL) stock, focusing on its dividend and stock split history. It indicates that the company has not distributed any dividends over the past five years. The page also presents current stock performance data and links …

NXL|Nexalin Technology Inc|Price:0.481|Chg%:+0.013

Nexalin Technology Inc. (NXL) is trading at $0.481, experiencing a 2.82% increase. The company specializes in neurostimulation products for mental health, with strong revenue growth and high institutional ownership. Analysts rate NXL as a "Buy" with a target price of $2.00, indicating significant upside …

Nexalin Technology, Inc. Revenue Breakdown – NASDAQ:NXL

Nexalin Technology, Inc. (NASDAQ: NXL) generated $302.00K USD in revenue last year. The "Device" segment was the top performer, contributing $136.00K USD, significantly up from $55.50K USD in the previous year. China was the leading geographical contributor, accounting for $190.30K USD of the total …

Nexalin Technology Announces Two Clinical Abstracts Accepted for Presentation at the 2026 NYC Neuromodulation Conference Highlighting Preliminary Clinical Results Across Anxiety, Depression, Insomnia and Quality of Life

Nexalin Technology, Inc. announced that two clinical abstracts evaluating its proprietary DIFS™ 15 mA, 77.5 Hz treatment platform have been accepted for presentation at the 2026 NYC Neuromodulation Conference. The data highlights significant improvements in anxiety, depression, insomnia, and quality of life, with an …

Nexalin Technology (NXL) Registration filing Summary

Nexalin Technology (NXL) designs and develops non-invasive neurostimulation devices for mental health conditions, focusing on anxiety, insomnia, and depression. The company utilizes proprietary 15 milliamp waveform technology and generates revenue through device sales, leasing, and recurring electrode sales. Recent financial activities include a $5.25 …

Nuix Limited (ASX:NXL) Share Price in Focus After a Sharp Single-Session Move

Should You Think About Buying Nuix Limited (ASX:NXL) Now?

Nuix Limited (ASX:NXL) is definitely on the radar of institutional investors who own 34% of the company

Nuix Limited (ASX:NXL) May Have Run Too Fast Too Soon With Recent 33% Price Plummet

After losing 51% in the past year, Nuix Limited (ASX:NXL) institutional owners must be relieved by the recent gain